Annual Cash & Cash Equivalents
$68.10 M
+$36.65 M+116.55%
December 31, 2022
Summary
- As of February 10, 2025, GRNA annual cash & cash equivalents is $68.10 million, with the most recent change of +$36.65 million (+116.55%) on December 31, 2022.
- During the last 3 years, GRNA annual cash & cash equivalents has risen by +$42.18 million (+162.76%).
Performance
GRNA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$32.35 M
-$35.75 M-52.49%
March 31, 2023
Summary
- As of February 10, 2025, GRNA quarterly cash and cash equivalents is $32.35 million, with the most recent change of -$35.75 million (-52.49%) on March 31, 2023.
- Over the past year, GRNA quarterly cash and cash equivalents has dropped by -$50.87 million (-61.13%).
Performance
GRNA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GRNA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +116.5% | -61.1% |
| 3 y3 years | +162.8% | -66.0% |
| 5 y5 years | +162.8% | -66.0% |
GRNA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -53.8% | -67.1% | -2.8% |
| 5 y | 5-year | -28.4% | -61.9% | -67.1% | -2.8% |
| alltime | all time | -28.4% | -61.9% | -67.1% | -2.8% |
GreenLight Biosciences Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $32.35 M(-52.5%) |
| Dec 2022 | $68.10 M | $68.10 M(-30.8%) |
| Sep 2022 | - | $98.35 M(+122.9%) |
| Jun 2022 | - | $44.13 M(-47.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $83.22 M(+164.7%) |
| Dec 2021 | $31.45 M(-66.9%) | $31.45 M(-9.5%) |
| Sep 2021 | - | $34.75 M(-63.4%) |
| Dec 2020 | $95.07 M(+266.8%) | $95.07 M |
| Dec 2019 | $25.92 M | - |
FAQ
- What is GreenLight Biosciences Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GreenLight Biosciences Holdings?
- What is GreenLight Biosciences Holdings annual cash & cash equivalents year-on-year change?
- What is GreenLight Biosciences Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GreenLight Biosciences Holdings?
- What is GreenLight Biosciences Holdings quarterly cash and cash equivalents year-on-year change?
What is GreenLight Biosciences Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of GRNA is $68.10 M
What is the all time high annual cash & cash equivalents for GreenLight Biosciences Holdings?
GreenLight Biosciences Holdings all-time high annual cash & cash equivalents is $95.07 M
What is GreenLight Biosciences Holdings annual cash & cash equivalents year-on-year change?
Over the past year, GRNA annual cash & cash equivalents has changed by +$36.65 M (+116.55%)
What is GreenLight Biosciences Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GRNA is $32.35 M
What is the all time high quarterly cash and cash equivalents for GreenLight Biosciences Holdings?
GreenLight Biosciences Holdings all-time high quarterly cash and cash equivalents is $98.35 M
What is GreenLight Biosciences Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, GRNA quarterly cash and cash equivalents has changed by -$50.87 M (-61.13%)